Skip to main content
TipRanks
Go Ultimate75% OFF

Steve Kanzer Insider Profile

4 Followers

Steve Kanzer, Prior Director, Ten Percent Owner at Theriva Biologics, holds 2.57M shares in Theriva Biologics (Ticker: TOVX), holds 1.28M shares in Soligenix (Ticker: SNGX). Most recently, Steve Kanzer Sold ― shares of Theriva Biologics on May 02, 2014 for an estimated value of $7.15M.

Steve Kanzer's Trading History

TOVX
Theriva Biologics
May 02, 2014Prior Director, Ten Percent OwnerInformative Sell7.15M$370.19K
SNGX
Soligenix
―Director―$411.59K

You May Also Like

Steve Kanzer insider profile FAQ

What is the percentage of profitable transactions made by Steve Kanzer?
The percentage of profitable transactions made by Steve Kanzer is 0%.
What is the average return per transaction made by Steve Kanzer?
The average return per transaction made by Steve Kanzer is -53.10%.
What stocks does Steve Kanzer hold?
Steve Kanzer holds: TOVX, SNGX stocks.
What was Steve Kanzer’s latest transaction?
Steve Kanzer’s latest transaction was an Informative Sell of $7.15M.
What was Steve Kanzer's most profitable transaction?
Steve Kanzer’s most profitable transaction was an Informative Sell of TOVX stock on April 30, 2014. The return on the trade was -44.80%.
What is Steve Kanzer's role in Theriva Biologics?
Steve Kanzer's role in Theriva Biologics is Prior Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.